- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 405/14 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Patent holdings for IPC class C07D 405/14
Total number of patents in this class: 11461
10-year publication summary
|
693
|
650
|
690
|
788
|
819
|
786
|
800
|
1016
|
926
|
742
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17706 |
296 |
| Merck Patent GmbH | 5752 |
212 |
| Bristol-myers Squibb Company | 4826 |
205 |
| Boehringer Ingelheim International GmbH | 4636 |
190 |
| Novartis AG | 10612 |
173 |
| Janssen Pharmaceutica N.V. | 3358 |
150 |
| Vertex Pharmaceuticals Incorporated | 1630 |
147 |
| Merck Sharp & Dohme LLC | 3732 |
141 |
| Gilead Sciences, Inc. | 2106 |
140 |
| LT Materials Co., Ltd. | 414 |
139 |
| Takeda Pharmaceutical Company Limited | 2721 |
138 |
| Pfizer Inc. | 3401 |
131 |
| Idemitsu Kosan Co., Ltd. | 4223 |
114 |
| F. Hoffmann-La Roche AG | 7937 |
113 |
| Genentech, Inc. | 4016 |
102 |
| Samsung SDI Co., Ltd. | 8901 |
93 |
| Samsung Display Co., Ltd. | 36317 |
87 |
| Vanderbilt University | 1941 |
82 |
| Epizyme, Inc. | 375 |
74 |
| AstraZeneca AB | 2857 |
70 |
| Other owners | 8664 |